Neuroimaging Spectrum of Inherited Neurotransmitter Disorders

Neuropediatrics. 2020 Feb;51(1):6-21. doi: 10.1055/s-0039-1698422. Epub 2019 Oct 21.

Abstract

Inherited neurotransmitter disorders are rare neurometabolic conditions which encompass genetic disorders of neurotransmitter metabolism or transport. The clinical manifestations of these rare disorders are often nonspecific, ranging from encephalopathies and seizures to movement disorders. As a consequence, neurotransmitter disorders are underrecognized and often misdiagnosed. Accurate and timely diagnosis is, however, of utmost importance, given the availability of therapeutic strategies. A high index of clinical suspicion and familiarity with the neuroimaging phenotypes is therefore crucial. While the imaging features of various neurotransmitter disorders often overlap and are nonspecific, imaging can be helpful in providing useful clues to guide the diagnostic algorithm for uncommon conditions in a neonate presenting with nonspecific neurological symptoms. In this review paper, we aim to bring together current knowledge of neuroimaging phenotypes associated with inherited (primary) disorders of neurotransmitter biosynthesis. Magnetic resonance imaging phenotypes of disorders of monoamine biosynthesis, primary cerebral folate deficiency, disorders of pyridoxine metabolism, disorders of gamma-aminobutyric acid metabolism, nonketotic hyperglycinemia (glycine encephalopathy), disorders of serine biosynthesis, and cerebral creatine deficiency syndrome will be discussed and illustrated with case examples.

Publication types

  • Review

MeSH terms

  • Amino Acid Metabolism, Inborn Errors* / diagnostic imaging
  • Amino Acid Metabolism, Inborn Errors* / metabolism
  • Amino Acid Metabolism, Inborn Errors* / pathology
  • Amino Acid Metabolism, Inborn Errors* / physiopathology
  • Biogenic Monoamines* / metabolism
  • Brain Diseases, Metabolic* / diagnostic imaging
  • Brain Diseases, Metabolic* / metabolism
  • Brain Diseases, Metabolic* / pathology
  • Brain Diseases, Metabolic* / physiopathology
  • Humans
  • Neuroimaging*

Substances

  • Biogenic Monoamines